Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianlai Shi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Breast (Edinburgh, Scotland)|November 14, 2022
Trastuzumab-based regimens beyond progression: A crucial treatment option for HER2+ advanced/metastatic breast cancerThibaut Sanglier, Ryan Ross, Tianlai Shi, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2019
A novel mechanism-based pharmacokinetic-pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteriaAnders N Kristoffersson, Caterina Bissantz, Rusudan Okujava, et al.
Cell Reports|April 2, 2014
Rif1 controls DNA replication timing in yeast through the PP1 phosphatase Glc7Stefano Mattarocci, Maksym Shyian, Laure Lemmens, et al.
Cell|June 11, 2013
Rif1 and Rif2 shape telomere function and architecture through multivalent Rap1 interactionsTianlai Shi, Richard D Bunker, Stefano Mattarocci, et al.
Nature Structural & Molecular Biology|June 13, 2017
Rif1 maintains telomeres and mediates DNA repair by encasing DNA endsStefano Mattarocci, Julia K Reinert, Richard D Bunker, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Discovery of Potent and Efficacious Influenza PB2 InhibitorsJun Wu, Yongfu Liu, Dongbo Li, et al.
Plos Pathogens|September 1, 2020
Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assemblyAngeles Mecate-Zambrano, Swathi Sukumar, Guiscard Seebohm, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In VivoHassan Javanbakht, Henrik Mueller, Johanna Walther, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Breast (Edinburgh, Scotland)|November 14, 2022
Trastuzumab-based regimens beyond progression: A crucial treatment option for HER2+ advanced/metastatic breast cancerThibaut Sanglier, Ryan Ross, Tianlai Shi, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2019
A novel mechanism-based pharmacokinetic-pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteriaAnders N Kristoffersson, Caterina Bissantz, Rusudan Okujava, et al.
Cell Reports|April 2, 2014
Rif1 controls DNA replication timing in yeast through the PP1 phosphatase Glc7Stefano Mattarocci, Maksym Shyian, Laure Lemmens, et al.
Cell|June 11, 2013
Rif1 and Rif2 shape telomere function and architecture through multivalent Rap1 interactionsTianlai Shi, Richard D Bunker, Stefano Mattarocci, et al.
Nature Structural & Molecular Biology|June 13, 2017
Rif1 maintains telomeres and mediates DNA repair by encasing DNA endsStefano Mattarocci, Julia K Reinert, Richard D Bunker, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Discovery of Potent and Efficacious Influenza PB2 InhibitorsJun Wu, Yongfu Liu, Dongbo Li, et al.
Plos Pathogens|September 1, 2020
Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assemblyAngeles Mecate-Zambrano, Swathi Sukumar, Guiscard Seebohm, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In VivoHassan Javanbakht, Henrik Mueller, Johanna Walther, et al.
Pageof 1